Literature DB >> 25308783

Mechanism of enzymatic reaction and protein-protein interactions of PLD from a 3D structural model.

Madhu Mahankali1, Gerald Alter1, Julian Gomez-Cambronero2.   

Abstract

The phospholipase D (PLD) superfamily catalyzes the hydrolysis of cell membrane phospholipids generating the key intracellular lipid second messenger phosphatidic acid. However, there is not yet any resolved structure either from a crystallized protein or from NMR of any mammalian PLDs. We propose here a 3D model of the PLD2 by combining homology and ab initio 3 dimensional structural modeling methods, and docking conformation. This model is in agreement with the biochemical and physiological behavior of PLD in cells. For the lipase activity, the N- and C-terminal histidines of the HKD motifs (His 442/His 756) form a catalytic pocket, which accommodates phosphatidylcholine head group (but not phosphatidylethanolamine or phosphatidyl serine). The model explains the mechanism of the reaction catalysis, with nucleophilic attacks of His 442 and water, the latter aided by His 756. Further, the secondary structure regions superimposed with bacterial PLD crystal structure, which indicated an agreement with the model. It also explains protein-protein interactions, such as PLD2-Rac2 transmodulation (with a 1:2 stoichiometry) and PLD2 GEF activity both relevant for cell migration, as well as the existence of binding sites for phosphoinositides such as PIP2. These consist of R236/W238 and R557/W563 and a novel PIP2 binding site in the PH domain of PLD2, specifically R210/R212/W233. In each of these, the polar inositol ring is oriented towards the basic amino acid Arginine. Since tumor-aggravating properties have been found in mice overexpressing PLD2 enzyme, the 3D model of PLD2 will be also useful, to a large extent, in developing pharmaceuticals to modulate its in vivo activity.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Ab initio 3 dimensional structural modeling; Docking conformation; Enzyme catalysis; Homology; PLD; Phospholipids

Mesh:

Substances:

Year:  2014        PMID: 25308783      PMCID: PMC4314346          DOI: 10.1016/j.cellsig.2014.09.008

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  63 in total

Review 1.  Mammalian phospholipase D structure and regulation.

Authors:  M A Frohman; T C Sung; A J Morris
Journal:  Biochim Biophys Acta       Date:  1999-07-30

2.  Assessment of CAPRI predictions in rounds 3-5 shows progress in docking procedures.

Authors:  Raúl Méndez; Raphaël Leplae; Marc F Lensink; Shoshana J Wodak
Journal:  Proteins       Date:  2005-08-01

3.  Assignment of human PLD2 to chromosome band 17p13.1 by fluorescence in situ hybridization.

Authors:  S H Park; S H Ryu; P G Suh; H Kim
Journal:  Cytogenet Cell Genet       Date:  1998

4.  Novel functions of the phospholipase D2-Phox homology domain in protein kinase Czeta activation.

Authors:  Jong Hyun Kim; Jung Hwan Kim; Motoi Ohba; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

5.  Phospholipase D couples survival and migration signals in stress response of human cancer cells.

Authors:  Yang Zheng; Vanessa Rodrik; Alfredo Toschi; Ming Shi; Li Hui; Yingjie Shen; David A Foster
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

6.  The elucidation of novel SH2 binding sites on PLD2.

Authors:  M Di Fulvio; N Lehman; X Lin; I Lopez; J Gomez-Cambronero
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

7.  Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Julian Gomez-Cambronero
Journal:  Cell Signal       Date:  2007-10-13       Impact factor: 4.315

8.  Structural analysis of human phospholipase D1.

Authors:  T C Sung; Y Zhang; A J Morris; M A Frohman
Journal:  J Biol Chem       Date:  1999-02-05       Impact factor: 5.157

9.  Functional anatomy of phospholipid binding and regulation of phosphoinositide homeostasis by proteins of the sec14 superfamily.

Authors:  Gabriel Schaaf; Eric A Ortlund; Kimberly R Tyeryar; Carl J Mousley; Kristina E Ile; Teresa A Garrett; Jihui Ren; Melissa J Woolls; Christian R H Raetz; Matthew R Redinbo; Vytas A Bankaitis
Journal:  Mol Cell       Date:  2008-02-01       Impact factor: 17.970

10.  I-TASSER server for protein 3D structure prediction.

Authors:  Yang Zhang
Journal:  BMC Bioinformatics       Date:  2008-01-23       Impact factor: 3.169

View more
  6 in total

1.  Two sites of action for PLD2 inhibitors: The enzyme catalytic center and an allosteric, phosphoinositide biding pocket.

Authors:  Ramya Ganesan; Madhu Mahankali; Gerald Alter; Julian Gomez-Cambronero
Journal:  Biochim Biophys Acta       Date:  2014-12-20

Review 2.  Integrative computational approach for genome-based study of microbial lipid-degrading enzymes.

Authors:  Tayvich Vorapreeda; Chinae Thammarongtham; Kobkul Laoteng
Journal:  World J Microbiol Biotechnol       Date:  2016-06-04       Impact factor: 3.312

3.  Human PLD structures enable drug design and characterization of isoenzyme selectivity.

Authors:  Claire M Metrick; Emily A Peterson; Joseph C Santoro; Istvan J Enyedy; Paramasivam Murugan; TeYu Chen; Klaus Michelsen; Michael Cullivan; Kerri A Spilker; P Rajesh Kumar; Tricia L May-Dracka; Jayanth V Chodaparambil
Journal:  Nat Chem Biol       Date:  2020-02-10       Impact factor: 15.040

4.  Acinetobacter baumannii Virulence Is Mediated by the Concerted Action of Three Phospholipases D.

Authors:  Julia Stahl; Holger Bergmann; Stephan Göttig; Ingo Ebersberger; Beate Averhoff
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

Review 5.  Phosphatidylinositol Kinases and Phosphatases in Entamoeba histolytica.

Authors:  Kumiko Nakada-Tsukui; Natsuki Watanabe; Tomohiko Maehama; Tomoyoshi Nozaki
Journal:  Front Cell Infect Microbiol       Date:  2019-06-06       Impact factor: 5.293

Review 6.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.